First Clinical Outcomes With New Full Range Of Vision Iol: The Next Generation Optic Design

To present the first clinical results with a novel spiral full range of vision intraocular lens (IOL) to restore the visual function.

Rothschild Foundation Hospital, Paris, France

In this retrospective, single-centre, observational, clinical study, a total of 20 patients (40 eyes) who were candidate for bilateral multifocal lens implantation were included. Evaluation conducted 1-2 weeks and 1-3 months after the surgery includes corrected and uncorrected visual acuities at far (4 m), intermediate (66 cm), and near distance (40 cm), manifest refraction, defocus, and patients reported outcomes and satisfaction.

The first implantation will occur in the next few weeks and we expect to have all the results available by the end of June 2024.

Anticipated outcomes encompass functional visual acuity at far, intermediate and near distances, coupled with the defocus curve.

In conclusion, the growing patient preference for spectacle independence post crystalline lens removal is a well-established phenomenon. Traditional monofocal IOLs may fall short in meeting these increasing expectations.

Spiral multifocal lenses is an innovative concept aimed to provide wider depth perception while reducing the reliance on larger apertures in real word scenarios. We expect the new spiral IOL evaluated in this study to be a very promising option to address the desire for a higher level of spectacle independence in these patients.